Michael Patterson is the CEO of US Cannabis Pharmaceutical Research and Development LLC (US Cannabis), a privately-held developmental consulting firm which was established in 2014 with the mission of moving society forward through legalized cannabis. US Cannabis develops the legal cannabis/hemp/cbd markets globally across all platforms (education, cultivation, production, dispensing, research and development, management operations and compliance, and physician services). US Cannabis currently works with national, state, and local governments, sovereign nations, and public/private companies in all aspects of the cannabis/hemp/CBD industry throughout the United States and Internationally. Mr. Patterson is President and Executive board member of MGMC-Pharma Group, an international medical cannabis pharmaceutical corporation with EU- GMP cannabis cultivation, production, and export/distribution licenses in 6 East African Countries and offices in Australia, Italy, and the United States.